Clinical trial

Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy

NCT04932460

Study summary

ClinicalTrials.gov

Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

PROCEDURE · Unmapped registry intervention CEUS Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention blue dye Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-06-15

PhaseNA

Conditions

Breast Neoplasmsunresolved

Neoadjuvant Therapyunresolved

Sentinel Lymph Node Biopsyunresolved

Interventions

CEUSPROCEDURE

blue dyePROCEDURE

Sponsors & collaborators

First Affiliated Hospital, Sun Yat-Sen Universitylead sponsor

The Seventh Affiliated Hospital of Sun Yat-sen Universitycollaborator

Affiliated Hospital of Guangdong Medical Universitycollaborator

First Affiliated Hospital of Shantou University Medical Collegecollaborator

Mapped research locations

GuangzhouGuangdong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04932460 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.